Patent application number | Description | Published |
20110239306 | DATA LEAK PROTECTION APPLICATION - A data leak protection method for managing user interaction with a computing device, the computing device comprising a kernel mode of operation and a user mode of operation, the method comprising: monitoring the kernel mode of the computing device in order to detect user-initiated events; determining whether a given user-initiated event has a forbidden status or an allowed status; performing an action in dependence on the status of the given user-initiated event. | 09-29-2011 |
20130205380 | IDENTITY VERIFICATION - A method of verifying the identity of a user comprising: initiating ( | 08-08-2013 |
20140281945 | SYSTEM AND METHOD OF ENCODING CONTENT AND AN IMAGE - A method of encoding content data into a digital image that includes determining bit values of a pixel within the digital image, modifying the bit values within the pixel based on content data to be encoded in order to encode the content data into the digital image, wherein determining the bit values of a pixel within the digital image comprises determining a binary representation of the bit values of the pixel and wherein modifying the bit values comprises determining a binary representation of the content data to be encoded within the pixel and encoding the content data using a reversible binary operation. | 09-18-2014 |
20140281946 | SYSTEM AND METHOD OF ENCODING CONTENT AND AN IMAGE - A method of verifying the identity of a user at an authentication server that includes receiving user data relating to a signature gesture entered by a user at a computing device, the user data having a plurality of sample points, verifying the user data at the authentication server by comparing to reference signature data, encoding a verification message within a digital image, and notifying the user that their identity has been verified on the basis of the user data received from the computing device. | 09-18-2014 |
20140283005 | BEHAVIOMETRIC SIGNATURE AUTHENTICATION SYSTEM AND METHOD - The present invention discloses a method of verifying the authenticity of a provided signature, comprising the steps of: receiving a set of sampled data points, each sampled data point being associated with a different position along the signature; identifying a set of characterising nodes within the set of sampled data points using a set of predetermined characterising nodes comprised in a pre-stored user profile; determining if each identified characterising node lies within a predetermined threshold range of a corresponding predetermined characterising node; and generating a positive verification when the characterising nodes lie within the predetermined threshold range. A system arranged to carry out the method is also disclosed. | 09-18-2014 |
Patent application number | Description | Published |
20100028354 | COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE - Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual. | 02-04-2010 |
20120201814 | COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE - Disclosed are domain antibodies that monovalently bind CD28. Domain antibodies that are monovalent for binding of CD28 can inhibit CD28 activity. In one aspect, a domain antibody consists of or comprises a single immunoglobulin variable domain that specifically binds and antagonizes the activity of CD28, in an aspect, without substantially agonizing CD28 activity. In another aspect, the domain antibody is a human domain antibody. The disclosure further encompasses methods of antagonizing CD80 and/or CD86 interactions with CD28 in an individual and methods of treating diseases or disorders involving CD80 and/or CD86 interactions with CD28, the methods involving administering a domain antibody to the individual. | 08-09-2012 |
20130095109 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L - Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single V | 04-18-2013 |
20130109846 | COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE | 05-02-2013 |
20140099707 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L - Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single V | 04-10-2014 |
20150023976 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L - Antibody polypeptides that specifically bind human CD40L are provided. The antibody polypeptides do not activate platelets. The antibody polypeptides are useful in the treatment of diseases involving CD40L activation, such as graft-related diseases and autoimmune diseases. The antibody polypeptides may be domain antibodies (dAbs) comprising a single V | 01-22-2015 |